Logo.jpg
Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Products
April 25, 2022 09:08 ET | Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 25, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:ENDV) today announced an agreement with NAMSA – a leading Global Contract Research Organization (CRO) and...
Worldwide Medical Coding Industry to 2027 - Featuring Access Healthcare, Medical Records Associates and Optum Among Others
April 08, 2022 05:53 ET | Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Medical Coding Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
July 23, 2021 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
22157.jpg
United States Medical Coding Markets, 2019-2020 & 2021-2028
May 20, 2021 04:08 ET | Research and Markets
Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "U.S. Medical Coding Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The United States (U.S.) medical coding market is...
22157.jpg
United States Medical Coding Market Report 2021-2028 - Frequent Revisions in the Medical Codes is One of the Major Parameter Driving the Market Growth
May 10, 2021 07:53 ET | Research and Markets
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "U.S. Medical Coding Market Size, Share & Trends Analysis Report by Classification System (ICD, CPT, HCPCS), by Component (In-house, Outsourced) and...